Andrew Ashe - President, Chief Operating Officer and General Counsel at Verve Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
President, Chief Operating Officer and General Counsel
Stock Symbol
VERV on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

Andrew Ashe - trading volume in the past year for Verve Therapeutics, Inc.

Holdings reported by Andrew Ashe for Verve Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 349K $1.45M $4.15 Apr 2, 2025 Direct
Restricted Stock Units 27K $112K $4.15 Apr 1, 2025 Direct Common Stock
Stock Option (right to buy) 225K Jan 8, 2025 Direct Common Stock

Transactions reported by Andrew Ashe for Verve Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.